PI 3-Kinase p110 gamma Antibody (304103) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2999JF669

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Rat IgG2A Clone # 304103
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human PI 3-Kinase p110 gamma
Lys298-Leu467
Accession # P48736
Lys298-Leu467
Accession # P48736
Specificity
Detects endogenous human PI 3-Kinase p110 gamma in Western blots.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for PI 3-Kinase p110 gamma Antibody (304103) [Janelia Fluor® 669]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PI 3-Kinase p110 gamma
Long Name
Protein Tyrosine Phosphatase 1G
Alternate Names
p120-PI3K, PI 3Kinase p110 gamma, PI3CG, PI3K-gamma, PIK3CG
Gene Symbol
PIK3CG
Additional PI 3-Kinase p110 gamma Products
Product Documents for PI 3-Kinase p110 gamma Antibody (304103) [Janelia Fluor® 669]
Product Specific Notices for PI 3-Kinase p110 gamma Antibody (304103) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...